| Term 
 
        | What is the difference between systolic and diastolic HF? |  | Definition 
 
        | -Systolic - most common, defect in contractility. See a decreased ejection fraction of <40 - Diastolic - Defect in relaxation - restriction in filling but normal EF. Can be caused by mitral/tricuspid stenosis, hypertrophy
 |  | 
        |  | 
        
        | Term 
 
        | What are symptoms of left sided heart failure and why? |  | Definition 
 
        | Left side is fed from the lungs. As it fails due to stenosis, and MI, or myopathy/HTN, blood/fluid backs up into the lungs --> fatigue, congestion, edema Increased LVEDV and preload, decreased SV
 |  | 
        |  | 
        
        | Term 
 
        | What are symptoms of right sided heart failure and why? |  | Definition 
 
        | Usually caused by the left side failing or COPD/pulmonary valve problems, blood backs up into the systemic circuit leading to venous congestion |  | 
        |  | 
        
        | Term 
 
        | What is F-S law and how does it relate to HF? |  | Definition 
 
        | As a heart stretches to increase contractility, heart will return to normal function for a time but lose it's ability to compensate.  Leads to further dmg of myocardium |  | 
        |  | 
        
        | Term 
 
        | What is the Law of Laplace and how does it relate to ventricular hypertrophy? |  | Definition 
 
        | An increased wall thickness will decrease tension, but the muscle operates at lower inotropy |  | 
        |  | 
        
        | Term 
 
        | As CO decreases in HF, what peripheral mechanisms activate? |  | Definition 
 
        | - SNS - increased HR --> increased SV - RAAS - increase volume/CO
 - ADH - promotes water retention
 - ANP/BNP - released in times of stress, tries to counteract RAAS
 |  | 
        |  | 
        
        | Term 
 
        | What factors can lead to heart failure? |  | Definition 
 
        | - An increase in metabolic demands such as infection or hyperthyroidism - Increased volume/preload due to sodium, water, or renal failure
 - Increased afterload due to HTN
 - Impaired inotropy due to drugs or ischemia
 - Non-compliance in meds
 |  | 
        |  | 
        
        | Term 
 
        | What compensatory mechanisms are targets for interventions? |  | Definition 
 
        | - Increased workload --> decr activity - Increased preload --> decr salt/fluid, use loop diuretics and Aldactone
 - Increased Afterload - use vasodilators and AceI/ARBs
 - Decreased contractility - use positive inotropes
 - Increased SNS - use beta blockers
 |  | 
        |  | 
        
        | Term 
 
        | What medications contribute to HF? |  | Definition 
 
        | - Non-DHP CCBs - NEVER use them in a HF patient - NSAIDS
 - TZDs - Actos and avandia
 |  | 
        |  | 
        
        | Term 
 
        | What are the most common S/S of HF? |  | Definition 
 
        | SOB and fatigue, s3 gallop, pitting edema, JVD and enlarged heart. Orthopnea - needs pillows to sleep at night, sign of congestion
 |  | 
        |  | 
        
        | Term 
 
        | What are the ACC/AHA stages for HF? |  | Definition 
 
        | A - At risk but no evidence - HTN, DM, atherosclerotic disease B - Evidence of disease but no symptoms: EF < 40%
 C - EF < 40% and symptoms visible
 D - Symptoms persist despite maximum therapy, ADHF
 ** Cannot go up and down functional classes
 |  | 
        |  | 
        
        | Term 
 
        | What are the NYHA classifications for HF? |  | Definition 
 
        | - Class 1 - Asymptomatic - Class 2 - slight limitation, no symptoms at rest
 - Class 3 - Marked limitation, comfortable only at rest
 - Class 4 - Must be at complete rest for any relief
 ** May move between catagories
 |  | 
        |  | 
        
        | Term 
 
        | What are the goals of treatment at Stage A HF? |  | Definition 
 
        | - Risk factor control - stop smoking, treat HTN, DM2, lipids - Every patient at risk for Heart Failure receives an Ace Inhibitor (or ARB) even when asymptomatic
 |  | 
        |  | 
        
        | Term 
 
        | In stage B HF, what is the goal of therapy? |  | Definition 
 
        | If EF < 40% OR patient has an MI: Initiate appropriate beta blocker therapy. Therapy must be STOPPED if bronchospasms, severe depression, or ADHF.
 For Lethargy and bradycardia, reduce dose.
 |  | 
        |  | 
        
        | Term 
 
        | In Stage C of HF what becomes the goal of therapy? |  | Definition 
 
        | - Fluid overload : Add loop diuretic --> if no improvement, add Spironolactone --> If no improvement, add Bidil or Digoxin |  | 
        |  | 
        
        | Term 
 
        | When should Spironolactone or Eplerenone be used in HF patients? What are the doses? |  | Definition 
 
        | In stage C, when initial diuresis fails. Spironolactone 12.5 mg QD, max 25 mg BID. Better than Eplerenone according to RALES study. K must be < 5 and SCr < 2.5/2
 Use Eplerenone 25 mg only in post-MI patients
 |  | 
        |  | 
        
        | Term 
 
        | When are Hydralazine/ISDN and Digoxin used in HF patients? |  | Definition 
 
        | In stage C: - Bidil - for persistent symptoms in African American patients in place of or in addition to AceI (VHeft study)
 - Digoxin - as last line therapy, only to reduce hospitalizations, must stay withing a plasma conc of 0.5 - 1 ng/ml. Watch for Dig toxicity - halos
 |  | 
        |  | 
        
        | Term 
 
        | What drugs should be avoided in Stage C HF? |  | Definition 
 
        | - Class 1 and 2 antiarrhythmics - Non-DHP CCBs ALWAYS
 - NSAIDs
 - Corticosteroids, amphetamines, Minoxidil
 - Diabetes meds: TZDs and Metformin
 - Do not use triple combo of AceI + ARB + Spironolactone, 2 is fine
 |  | 
        |  | 
        
        | Term 
 
        | What counseling points are important in HF patients? |  | Definition 
 
        | Limit water and salt intake to 2 L/ 2 G. Get flu and pneumonia vaccine
 Weigh daily, get ins/outs
 |  | 
        |  | 
        
        | Term 
 
        | Which AceI are appropriate for HF therapy and their doses? |  | Definition 
 
        | - Enalapril/Vasotec - Start at 5 mg BID, titrate to 10 mg BID - Lisinopril/Prinivil - Start at 5 mg QD, titrate to 40 mg daily
 - Ramipril/Altace - Start at 2.5 mg QD, titrate to 5 BID
 Monitor BP, K, SCr
 |  | 
        |  | 
        
        | Term 
 
        | Which Beta Blockers are appropriate for HF therapy and what are their doses? |  | Definition 
 
        | - Bisoprolol/Zebeta - start at 1.25 mg qd, titrate to 10 mg daily - Metoprolol XL only - start at 12.5 mg qd, titrate to 200 mg QD
 - Carvedilol/Coreg - Start at 3.125 mg BID, titrate to 25 mg BID.
 Titrate every 2 weeks
 |  | 
        |  | 
        
        | Term 
 
        | What are the Doses and goals for diuretic therapy in HF patients? |  | Definition 
 
        | Use loop diuretics. Most common is Lasix starting 20-40 mg QD to BID w/ a max of 600 mg. May also use Bumetanide or Torsemide
 If additional diuresis is needed --> Metolazone 2.5-5 mg QD - BID with loop.
 |  | 
        |  | 
        
        | Term 
 
        | What ARBs are indicated for HF and what are their doses? |  | Definition 
 
        | - Candesartan/Atacand 4-8 mg QD, max 32 mg QD - Valsartan/Diovan 20-40 mg BID, max 160 mg BID
 - Losartan/Cozaar 25-50 mg, max 50-100 mg
 |  | 
        |  | 
        
        | Term 
 
        | When should HF patients receive anticoagulation? |  | Definition 
 
        | When they also have: AFib, prior VTE, stasis from bed rest. Give warfarin with an INR goal of 2-3 |  | 
        |  | 
        
        | Term 
 
        | How is diastolic HF treated? |  | Definition 
 
        | Treated exactly the same, except non-DHP CCB can be used |  | 
        |  | 
        
        | Term 
 
        | How do medications compare to CHF devices? |  | Definition 
 
        | Several drugs, including anti-arrhythmics, worsen mortality. Devices have positive life saving results. |  | 
        |  | 
        
        | Term 
 
        | What is an ICD and how does in work? |  | Definition 
 
        | For arrhythmias, senses Vtach and shocks back into normal sinus rhythm. Patient must by post-MI, have HF, have limitation in activity, an expectation of survival, or have HF and an arrhythmia
 Drugs increase or decrease Defib threshold, several of them anti-arrhythmics
 - Want concomitant beta blocker therapy
 |  | 
        |  | 
        
        | Term 
 
        | When is ventricular dyssynchrony and how is it treated? |  | Definition 
 
        | Ventricles do not contract at the same time due to a bundle block Biventricular device synchronizes heart.
 Eligible for CRT if: EF < 35% and sinus rhythm, and NYHA 3 or 4, and cardiac dyssynchrony
 |  | 
        |  | 
        
        | Term 
 
        | What pharmacological management is there of ICD and CRT? |  | Definition 
 
        | - do not want anticoagulated -- bridge therapy for 5 days, restart right after surgery - Continue ASA only if patient is moderate to high risk for a CV event
 - Antibiotic before implant, no antibiotic after
 |  | 
        |  | 
        
        | Term 
 
        | What are VADs, and in who are they used? |  | Definition 
 
        | Risk assessed through INTERMACS. Hooks up a continuous flow, requires battery pack. Has long term complications |  | 
        |  | 
        
        | Term 
 
        | What is the criteria and benefits of heart transplant? |  | Definition 
 
        | For Class D HF, Recurrent arrhythmia, dependence on Inotropes, cardiogenic shock Lots of contraindications - age, cancer, smoking, BMI, DM2
 Avg survival is 13 years
 |  | 
        |  |